| A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer G Arcangeli, B Saracino, S Gomellini, MG Petrongari, S Arcangeli, ... International Journal of Radiation Oncology* Biology* Physics 78 (1), 11-18, 2010 | 331 | 2010 |
| Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR spheres: radiobiologic considerations L Strigari, R Sciuto, S Rea, L Carpanese, G Pizzi, A Soriani, G Iaccarino, ... Journal of Nuclear Medicine 51 (9), 1377-1385, 2010 | 295 | 2010 |
| The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy L Strigari, M Konijnenberg, C Chiesa, M Bardies, Y Du, KS Gleisner, ... European journal of nuclear medicine and molecular imaging 41, 1976-1988, 2014 | 260 | 2014 |
| Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer S Arcangeli, L Strigari, S Gomellini, B Saracino, MG Petrongari, P Pinnarò, ... International Journal of Radiation Oncology* Biology* Physics 84 (5), 1172-1178, 2012 | 236 | 2012 |
| Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19 M Watanabe, D Caruso, D Tuccinardi, R Risi, M Zerunian, M Polici, ... Metabolism 111, 154319, 2020 | 230 | 2020 |
| Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective M Cremonesi, C Chiesa, L Strigari, M Ferrari, F Botta, F Guerriero, ... Frontiers in oncology 4, 210, 2014 | 209 | 2014 |
| Moderate hypofractionation in high-risk, organ-confined prostate cancer: final results of a phase III randomized trial G Arcangeli, B Saracino, S Arcangeli, S Gomellini, MG Petrongari, ... Journal of Clinical Oncology 35 (17), 1891-1897, 2017 | 196 | 2017 |
| Diffusion-weighted MR imaging in the evaluation of renal tumours E Squillaci, G Manenti, F Di Stefano, R Miano, L Strigari, G Simonetti Journal of Experimental and Clinical Cancer Research 23 (1), 39-46, 2004 | 194 | 2004 |
| International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres H Levillain, O Bagni, CM Deroose, A Dieudonné, S Gnesin, OS Grosser, ... European journal of nuclear medicine and molecular imaging 48, 1570-1584, 2021 | 191 | 2021 |
| Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer G Arcangeli, J Fowler, S Gomellini, S Arcangeli, B Saracino, ... International Journal of Radiation Oncology* Biology* Physics 79 (4), 1013-1021, 2011 | 189 | 2011 |
| EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseases H Hänscheid, C Canzi, W Eschner, G Flux, M Luster, L Strigari, ... European journal of nuclear medicine and molecular imaging 40, 1126-1134, 2013 | 175 | 2013 |
| Dosimetric and clinical advantages of deep inspiration breath-hold (DIBH) during radiotherapy of breast cancer V Bruzzaniti, A Abate, P Pinnarò, M D’Andrea, E Infusino, V Landoni, ... Journal of Experimental & Clinical Cancer Research 32, 1-7, 2013 | 148 | 2013 |
| Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials G Arcangeli, L Strigari, S Arcangeli Critical reviews in oncology/hematology 95 (3), 387-396, 2015 | 142 | 2015 |
| Endothelial NOS, estrogen receptor β, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer S Nanni, V Benvenuti, A Grasselli, C Priolo, A Aiello, S Mattiussi, ... The Journal of clinical investigation 119 (5), 1093-1108, 2009 | 138 | 2009 |
| Correlation of dose with toxicity and tumour response to 90Y- and 177Lu-PRRT provides the basis for optimization through individualized treatment planning M Cremonesi, ME Ferrari, L Bodei, C Chiesa, A Sarnelli, C Garibaldi, ... European journal of nuclear medicine and molecular imaging 45, 2426-2441, 2018 | 133 | 2018 |
| A meta-analysis of the abscopal effect in preclinical models: Is the biologically effective dose a relevant physical trigger? R Marconi, S Strolin, G Bossi, L Strigari PloS one 12 (2), e0171559, 2017 | 118 | 2017 |
| Kidney Dosimetry in 177Lu and 90Y Peptide Receptor Radionuclide Therapy: Influence of Image Timing, Time‐Activity Integration Method, and Risk Factors F Guerriero, ME Ferrari, F Botta, F Fioroni, E Grassi, A Versari, A Sarnelli, ... BioMed research international 2013 (1), 935351, 2013 | 115 | 2013 |
| Very-low-calorie ketogenic diets with whey, vegetable, or animal protein in patients with obesity: a randomized pilot study S Basciani, E Camajani, S Contini, A Persichetti, R Risi, L Bertoldi, ... The Journal of Clinical Endocrinology & Metabolism 105 (9), 2939-2949, 2020 | 112 | 2020 |
| The sexist behaviour of immune checkpoint inhibitors in cancer therapy? A Botticelli, CE Onesti, I Zizzari, B Cerbelli, P Sciattella, M Occhipinti, ... Oncotarget 8 (59), 99336, 2017 | 104 | 2017 |
| EANM dosimetry committee series on standard operational procedures: a unified methodology for 99mTc-MAA pre- and 90Y peri-therapy dosimetry in liver radioembolization … C Chiesa, K Sjogreen-Gleisner, S Walrand, L Strigari, G Flux, J Gear, ... EJNMMI physics 8, 1-44, 2021 | 97 | 2021 |
